Back
Day Range
$34.18
$36.70
52-Week Range
$28.53
$56.22
Volume
2,344,557
50D / 200D Avg
$42.01
/
$40.00
Prev Close
$34.86
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -633.8 | 0.3 |
| P/B | 2.2 | 2.9 |
| ROE % | -0.4 | 3.7 |
| Net Margin % | -0.3 | 3.8 |
| Rev Growth 5Y % | 9.2 | 10.0 |
| D/E | 0.8 | 0.2 |
Analyst Price Target
Hold
$52.13
+45.6%
Low: $35.00
High: $60.00
Forward P/E
16.5
Forward EPS
$2.12
EPS Growth (est.)
+0.0%
Est. Revenue
3.6 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$3.40
$3.35 – $3.44
|
4.2 B | 1 |
| FY2029 |
$3.11
$3.07 – $3.15
|
4.2 B | 1 |
| FY2028 |
$2.77
$2.73 – $2.80
|
3.9 B | 1 |
Key Takeaways
Revenue grew 9.19% annually over 5 years — modest growth
Earnings declined -107.60% over the past year
Generating 43.30M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 7.11%
Capital efficient — spends only 2.64% of revenue on capex
ROIC of 3.61% — low return on invested capital
Growth
Revenue Growth (5Y)
9.19%
Revenue (1Y)2.08%
Earnings (1Y)-107.60%
FCF Growth (3Y)-57.80%
Quality
Return on Equity
-0.41%
ROIC3.61%
Net Margin-0.25%
Op. Margin6.30%
Safety
Debt / Equity
0.83
Current Ratio1.73
Interest Coverage4.69
Valuation
P/E Ratio
-633.83
P/B Ratio2.22
EV/EBITDA33.22
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2.08% | Revenue Growth (3Y) | 7.67% |
| Earnings Growth (1Y) | -107.60% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 9.19% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3.44B | Net Income (TTM) | -8.60M |
| ROE | -0.41% | ROA | -0.14% |
| Gross Margin | 45.61% | Operating Margin | 6.30% |
| Net Margin | -0.25% | Free Cash Flow (TTM) | 43.30M |
| ROIC | 3.61% | FCF Growth (3Y) | -57.80% |
| Safety | |||
| Debt / Equity | 0.83 | Current Ratio | 1.73 |
| Interest Coverage | 4.69 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -633.83 | P/B Ratio | 2.22 |
| P/S Ratio | 1.59 | PEG Ratio | 6.94 |
| EV/EBITDA | 33.22 | Dividend Yield | 0.00% |
| Market Cap | 5.45B | Enterprise Value | 7.20B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.44B | 3.37B | 2.96B | 2.53B | 2.42B |
| Net Income | -8.60M | 113.10M | 427.20M | 296.60M | 277.10M |
| EPS (Diluted) | -0.15 | 0.76 | 2.90 | 1.99 | 1.81 |
| Gross Profit | 1.57B | 1.65B | 1.51B | 1.31B | 1.21B |
| Operating Income | 216.60M | 253.10M | 436.90M | 432.70M | 413.30M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 6.24B | 5.81B | 4.25B | 3.61B | 3.65B |
| Total Liabilities | 3.73B | 3.99B | 2.84B | 2.48B | 2.57B |
| Shareholders' Equity | 2.46B | 1.78B | 1.38B | 1.11B | 1.07B |
| Total Debt | 2.04B | 2.25B | 1.38B | 1.27B | 1.39B |
| Cash & Equivalents | 298.80M | 183.40M | 488.30M | 645.50M | 1.07B |
| Current Assets | 2.21B | 2.05B | 2.16B | 2.11B | 2.47B |
| Current Liabilities | 1.28B | 1.28B | 1.20B | 914.30M | 938.50M |